Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions Christine AhlströmTobias KroonJohan Gabrielsson Original Paper 10 October 2013 Pages: 623 - 638
Solution and implementation of distributed lifespan models Gilbert KochJohannes Schropp Original Paper 01 November 2013 Pages: 639 - 650
A modeling approach for compounds affecting body composition Peter GennemarkRasmus Jansson-LöfmarkJohan Gabrielsson Original Paper 25 October 2013 Pages: 651 - 667
Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats Roberto Heredia-OrtizMichèle Bouchard Original Paper 29 October 2013 Pages: 669 - 682
On the maintenance of hepatocyte intracellular pH 7.0 in the in-vitro metabolic stability assay Leonid M. BerezhkovskiySusan WongJason S. Halladay Original Paper 01 November 2013 Pages: 683 - 689
How to avoid unbounded drug accumulation with fractional pharmacokinetics Maud HennionEmmanuel Hanert Original Paper 16 November 2013 Pages: 691 - 700
Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach Hoi-Kei LonDongyang LiuWilliam J. Jusko Original Paper 14 November 2013 Pages: 701 - 712